Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: Projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons

Biochemical and Biophysical Research Communications

Volumn 451, Issue 2, 2014, Pages 276-281

  Katsurada, Kenichi ^a   Maejima, Yuko ^a   Nakata, Masanori ^a   Kodaira, Misato ^a   Suyama, Shigetomo ^a   Iwasaki, Yusaku ^a   Kario, Kazuomi ^a   Yada, Toshihiko ^a,b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Corticotropin releasing hormone; Feeding; Glucagon like peptide 1; Nesfatin 1; Nucleus tractus solitarius; Paraventricular nucleus

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; EXENDIN (9-39); GLUCAGON LIKE PEPTIDE 1; HORMONE ANTAGONIST; MEMBRANE PROTEIN; NESFATIN 1; OXYTOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; FEEDING BEHAVIOR; FOOD INTAKE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS;

CORTICOTROPIN-RELEASING HORMONE; FEEDING; GLUCAGON-LIKE PEPTIDE-1; NESFATIN-1; NUCLEUS TRACTUS SOLITARIUS; PARAVENTRICULAR NUCLEUS;

ANIMALS; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CORTICOTROPIN-RELEASING HORMONE; DNA-BINDING PROTEINS; EATING; FEEDING BEHAVIOR; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MALE; MICROINJECTIONS; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; NEURONS; OXYTOCIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, GLUCAGON; SOLITARY NUCLEUS;

EID: 84906933785     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.07.116     Document Type: Article

References (41)

1. I.M. Varndell, A.E. Bishop, K.L. Sikri, L.O. Uttenthal, S.R. Bloom, and J.M. Polak Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry J. Histochem. Cytochem. 33 1985 1080 1086
2. R.E. Amori, J. Lau, and A.G. Pittas Efficacy and safety of incretin therapy in type 2 diabetes: Systematic review and meta-analysis JAMA 298 2007 194 206
3. A. Astrup, S. Rössner, L. Van Gaal, A. Rissanen, L. Niskanen, M. Al Hakim, J. Madsen, M.F. Rasmussen, and M.E. Lean NN8022-1807 Study Group, Effects of liraglutide in the treatment of obesity: A randomised, double-blind, placebo-controlled study Lancet 374 2009 1606 1616
4. J. Rosenstock, L.J. Klaff, S. Schwartz, J. Northrup, J.H. Holcombe, K. Wilhelm, and M. Trautmann Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes Diabetes Care 33 2010 1173 1175
5. A. Flint, A. Raben, A. Astrup, and J.J. Holst Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans J. Clin. Invest. 101 1998 515 520
6. C. Verdich, A. Flint, J.P. Gutzwiller, E. Näslund, C. Beglinger, P.M. Hellström, S.J. Long, L.M. Morgan, J.J. Holst, and A. Astrup A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans J. Clin. Endocrinol. Metab. 86 2001 4382 4389
7. A. Flint, A. Raben, A.K. Ersbøll, J.J. Holst, and A. Astrup The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity Int. J. Obes. Relat. Metab. Disord. 25 2001 781 792
8. M.D. Turton, D. O'Shea, I. Gunn, S.A. Beak, C.M. Edwards, K. Meeran, S.J. Choi, G.M. Taylor, M.M. Heath, P.D. Lambert, J.P. Wilding, D.M. Smith, M.A. Ghatei, J. Herbert, and S.R. Bloom A role for glucagon-like peptide-1 in the central regulation of feeding Nature 379 1996 69 72
9. M. Tang-Christensen, P.J. Larsen, R. Göke, A. Fink-Jensen, D.S. Jessop, M. Møller, and S.P. Sheikh Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats Am. J. Physiol. 271 1996 R848 R856
10. K. Meeran, D. O'Shea, C.M. Edwards, M.D. Turton, M.M. Heath, I. Gunn, S. Abusnana, M. Rossi, C.J. Small, A.P. Goldstone, G.M. Taylor, D. Sunter, J. Steere, S.J. Choi, M.A. Ghatei, and S.R. Bloom Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat Endocrinology 140 1999 244 250
11. P.J. Larsen, M. Tang-Christensen, J.J. Holst, and C. Orskov Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem Neuroscience 77 1997 257 270
12. R.D. Cone Anatomy and regulation of the central melanocortin system Nat. Neurosci. 8 2005 571 578
13. S.L. Jin, V.K. Han, J.G. Simmons, A.C. Towle, J.M. Lauder, and P.K. Lund Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: An immunocytochemical study J. Comp. Neurol. 271 1988 519 532
14. S. Sarkar, C. Fekete, G. Légrádi, and R.M. Lechan Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus Brain Res. 985 2003 163 168
15. M. Tauchi, R. Zhang, D.A. D'Alessio, J.E. Stern, and J.P. Herman Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei J. Chem. Neuroanat. 36 2008 144 149
16. I. Merchenthaler, M. Lane, and P. Shughrue Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system J. Comp. Neurol. 403 1999 261 280
17. R. Göke, P.J. Larsen, J.D. Mikkelsen, and S.P. Sheikh Distribution of GLP-1 binding sites in the rat brain: Evidence that exendin-4 is a ligand of brain GLP-1 binding sites Eur. J. Neurosci. 7 1995 2294 2300
18. D.A. Sandoval, D. Bagnol, S.C. Woods, D.A. D'Alessio, and R.J. Seeley Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake Diabetes 57 2008 2046 2054
19. L.R. McMahon, and P.J. Wellman Decreased intake of a liquid diet in nonfood-deprived rats following intra-PVN injections of GLP-1 (7-36) amide Pharmacol. Biochem. Behav. 58 1997 673 677
20. L.R. McMahon, and P.J. Wellman PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats Am. J. Physiol. 274 1998 R23 R29
21. E. Valassi, M. Scacchi, and F. Cavagnini Neuroendocrine control of food intake Nutr. Metab. Cardiovasc. Dis. 18 2008 158 168
22. D. Richard, Q. Huang, and E. Timofeeva The corticotropin-releasing hormone system in the regulation of energy balance in obesity Int. J. Obes. Relat. Metab. Disord. 24 2000 S36 S39
23. B.R. Olson, M.D. Drutarosky, E.M. Stricker, and J.G. Verbalis Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: Evidence for central oxytocin inhibition of food intake Endocrinology 129 1991 785 791
24. S. Oh-I, H. Shimizu, T. Satoh, S. Okada, S. Adachi, K. Inoue, H. Eguchi, M. Yamamoto, T. Imaki, K. Hashimoto, T. Tsuchiya, T. Monden, K. Horiguchi, M. Yamada, and M. Mori Identification of nesfatin-1 as a satiety molecule in the hypothalamus Nature 443 2006 709 712
25. Y. Maejima, U. Sedbazar, S. Suyama, D. Kohno, T. Onaka, E. Takano, N. Yoshida, M. Koike, Y. Uchiyama, K. Fujiwara, T. Yashiro, T.L. Horvath, M.O. Dietrich, S. Tanaka, K. Dezaki, S. Oh-I, K. Hashimoto, H. Shimizu, M. Nakata, M. Mori, and T. Yada Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway Cell Metab. 10 2009 355 365
26. A. Stengel, M. Goebel, L. Wang, J. Rivier, P. Kobelt, H. Mönnikes, N.W. Lambrecht, and Y. Taché Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: Differential role of corticotropin- releasing factor2 receptor Endocrinology 150 2009 4911 4919
27. U. Sedbazar, Y. Maejima, M. Nakata, M. Mori, and T. Yada Paraventricular NUCB2/nesfatin-1 rises in synchrony with feeding suppression during early light phase in rats Biochem. Biophys. Res. Commun. 434 2013 434 438
28. D. Kohno, M. Nakata, F. Maekawa, K. Fujiwara, Y. Maejima, M. Kuramochi, T. Shimazaki, H. Okano, T. Onaka, and T. Yada Leptin suppresses ghrelin-induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase- and phosphodiesterase 3-mediated pathway Endocrinology 148 2007 2251 2263
29. Y. Maejima, D. Kohno, Y. Iwasaki, and T. Yada Insulin suppresses ghrelin-induced calcium signaling in neuropeptide Y neurons of the hypothalamic arcuate nucleus Aging (Albany NY) 3 2011 1092 1097
30. T. Yada, S. Vigh, and A. Arimura Pituitary adenylate cyclase activating polypeptide (PACAP) increases cytosolic-free calcium concentration in folliculo-stellate cells and somatotropes of rat pituitary Peptides 14 1993 235 239
31. 2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin Diabetes 52 2003 948 956
32. N. Vrang, M. Hansen, P.J. Larsen, and M. Tang-Christensen Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei Brain Res. 1149 2007 118 126
33. P.J. Larsen, M. Tang-Christensen, and D.S. Jessop Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat Endocrinology 138 1997 4445 4455
34. K. Gotoh, K. Fukagawa, T. Fukagawa, H. Noguchi, T. Kakuma, T. Sakata, and H. Yoshimatsu Glucagon-like peptide-1, corticotropin-releasing hormone, and hypothalamic neuronal histamine interact in the leptin-signaling pathway to regulate feeding behavior FASEB J. 19 2005 1131 1133
35. L. Rinaman, and E.E. Rothe GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 2002 R99 R106
36. D. Kohno, M. Nakata, Y. Maejima, H. Shimizu, U. Sedbazar, N. Yoshida, K. Dezaki, T. Onaka, M. Mori, and T. Yada Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding Endocrinology 149 2008 1295 1301
37. K.P. Kinzig, D.A. D'Alessio, J.P. Herman, R.R. Sakai, T.P. Vahl, H.F. Figueiredo, E.K. Murphy, and R.J. Seeley CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors J. Neurosci. 23 2003 6163 6170
38. N. Yoshida, Y. Maejima, U. Sedbazar, A. Ando, H. Kurita, B. Damdindorj, E. Takano, D. Gantulga, Y. Iwasaki, T. Kurashina, T. Onaka, K. Dezaki, M. Nakata, M. Mori, and T. Yada Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis Aging (Albany NY) 2 2010 775 784
39. J.R. Ussher, and D.J. Drucker Cardiovascular biology of the incretin system Endocr. Rev. 33 2012 187 215
40. G.L. Yosten, and W.K. Samson Nesfatin-1 exerts cardiovascular actions in brain: Possible interaction with the central melanocortin system Am. J. Physiol. Regul. Integr. Comp. Physiol. 297 2009 R330 R336
41. M. Tanida, and M. Mori Nesfatin-1 stimulates renal sympathetic nerve activity in rats NeuroReport 22 2011 309 312